Tag: Cancer therapy
Record funding for biotech firm ITM
Laboratory at ITM The Munich company was able to collect more than 200 million euros from investors. (Photo: ITM) Frankfurt In one of the largest private investment rounds in the…
Two Morphosys drugs are showing promise
Frankfurt After a long dry spell, the Munich-based biotech company Morphosys has regained some investor confidence with a number of positive reports. At a conference in the USA, the company…
Billion dollar deal for Munich biotech start-up Tubulis
Tubulis logo The young biotech company could earn over a billion dollars with the partnership. (Photo: tubules) Frankfurt The Munich-based biotech company Tubulis has agreed a potentially multi-billion dollar deal…
mRNA vaccine significantly reduces risk of skin cancer recurrence
Frankfurt Vaccines based on mRNA brought the breakthrough in the fight against the corona pandemic. Now the technology is also intended to decisively advance cancer therapy. Promising data are now…
Pfizer acquires cancer specialist Seagen for $43 billion
Pfizer logo The US pharmaceutical company takes over the cancer specialist Seagen for 43 billion dollars. (Photo: AP) Frankfurt The US group Pfizer is using its billions in revenue from…
Pfizer acquires cancer specialist Seagen for $43 billion
Pfizer The US pharmaceutical company takes over the cancer specialist Seagen for 43 billion dollars. (Photo: Bloomberg via Getty Images) Frankfurt The US pharmaceutical company Pfizer is planning one of…
US investors rely on German biotech companies
New York, Boston Caroll Neubauer has no doubt: “Germany is currently very interesting,” says the chief adviser to the US investment company Waterstreet, who is looking for investment opportunities in…
Biontech and Moderna in the expansion race
Frankfurt Your sales in the Covid business will fall significantly in the current year. In research, however, Moderna and Biontech are continuing to expand at high speed. This was made…
With antibodies to better cancer therapies
Biotech against tumors With the active ingredient in Catalym, cancer therapies should have a better impact. Frankfurt The biotech company Catalym from Martinsried near Munich has raised a total of…
Munich-based biotech company plans to go public on the Nasdaq
Radionuclide Cancer Therapy ITM has been producing radioisotopes for pharmaceutical companies from all over the world since the company was founded. (Photo: ITM) Frankfurt According to financial circles, the Munich-based…
ITM closes 500 million euro deal with Grand Pharma
Radionuclide cancer therapy ITM has been producing radioisotopes for pharmaceutical companies around the world since the company was founded. Photo: ITM Frankfurt The German biotech company ITM has found a…
Start-up wants to treat cancer with viruses
Immunotherapy Overall, product development is still in an early phase with many uncertainties. (Photo: dpa) Frankfurt Viruses are the great enemy in the fight against the corona pandemic. At the…